VEGFB and metabolic dysfunction-associated steatohepatitis: In more detail, the NASH model showed the strongest improvement, in which the pseudo-r2 increased from 23.4% to 27.8%, and the area under the receiver operating characteristic curve (AUC) increased from 73.7% to 76.6%, after the addition of the expression of just one SBC, VEGFB (Supplementary Table S15).